Bahija Jallal, Immunocore 🇬🇧 | Commercial, Diversity, and AI | E14

We’re super privileged to chat online with Bahija Jallal, the CEO of Immunocore. Immunocore is the largest biotech in the UK and the 5th largest in Europe with a market cap of just over 3 billion dollars. We talk about how Immunocore has helped thousands of cancer patients and has become a commercial biotech. We also talk about why she thinks gender and race diversity are a business case and how AI is changing protein and biologics engineering. 💎 ABOUT THE SPEAKERI’ve “known” Bahija for over 10 years, after reading her profile in a student pharma magazine when I was studying bioengineering in France. At that time, she was head of MedImmune and SVP R&D at AstraZeneca. Now as the CEO of Immunocore, with their pioneering T cell receptor platform, she has helped to bring incredible treatments for cancer patients to market. 🔗 LINKS MENTIONED- Bahija on the Breakthrough Labs podcast - https://open.spotify.com/episode/2X4xedUdJid9GeioRSkCrP?si=39d8c7511aab443f- Immatics builds on its PRAME Success (and competes with Immunocore) - [OncologyPipeline.com](https://www.oncologypipeline.com/apexonco/immatics-builds-its-prame-success)- The 25 Most Valuable Biotech Companies in Europe in 2025: ⁠https://flot.bio/most-valuable-biotech-companies-europe-2025/⁠📜 TRANSCRIPTRead the full transcript here: https://flot.bio/episode/bahija-jallal-immunocore/🫶 FOLLOW US- Newsletter: http://eepurl.com/h_fnmH- LinkedIn: https://www.linkedin.com/company/flot-bio/- X (Twitter): https://x.com/FlotBio🎙️ ABOUT FLOT.BIOFlot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 15k monthly views. Free.⭐️ SPONSORSHIPReady to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts!🙏 LIKE/FOLLOW/REVIEWDid you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.⏰ TIMESTAMPS[00:00:00] Intro[00:00:34] Welcome[00:01:46] Immunocore’s life-changing cancer drug[00:07:40] Commercializing Immunocore[00:13:46] Explaining the TCR technology[00:20:40] Targeting tumors with PRAME[00:23:26] Immunocore now and then[00:35:37] Why Bahija chose Immunocore[00:40:22] Top lessons from Bahija Jallal[00:45:48] How is risk appetite connected to innovation?[00:49:10] Diversity in biotech[01:00:59] Biological innovation[01:05:49] AI in protein engineering optimization[01:14:42] Thanks for listening